https://www.fool.com/investing/general/2016/12/10/is-biogens-aducanumab-a-game-changing-alzheimers-d.aspx
Is Biogen's Aducanumab a Game-Changing Alzheimer's Drug? | The Motley Fool
Dec 10, 2016 - The biotech has updated research suggesting its new clinical-stage drug could slow down Alzheimer's disease progression.
a game
https://www.neurologia.com.pl/index.php/issues/2021-vol-21-no-2/aducanumab-produced-a-clinically-meaningful-benefit-in-association-with-amyloid-lowering
Aducanumab produced a clinically meaningful benefit in association with amyloid lowering -...
in association withaducanumabproducedmeaningful